Stocks To Buy Now Blog

Stocks on Radar

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Shows Strong Market Performance in Past 3 Months

  • Remarkable gain of 62.1% over the last 12 weeks, indicating strong market momentum
  • H.C. Wainwright raised its price target to $15, reflecting a bullish outlook
  • Strong financial health with a current ratio of 1.37 and a low debt ratio of 0.064, showcasing a robust balance sheet

McEwen Mining (NYSE: MUX) (TSX: MUX) has been catching the attention of investors and analysts alike, demonstrating a robust performance in the stock market. With a significant uptick in its share price over the last 12 weeks, MUX has shown a remarkable gain of 62.1%. This trend of sustained positive momentum over time is a key indicator of the stock’s potential for continued growth, making it an attractive option for those looking to capitalize on price strength.

The company’s trading position at 84.2% of its 52-week high-low range puts the stock in range of a breakout. It’s worth keeping in mind that H.C. Wainwright recently increased its price target to $15, up from $13. This adjustment, as reported by TheFly, reflects a bullish outlook on MUX, with the price at the time of the announcement standing at $10.27. Such an endorsement from the brokerage community underscores the optimism surrounding McEwen Mining’s price performance.

McEwen Mining’s financial health further supports its strong market position. With a current ratio of 1.37, MUX demonstrates its capability to meet short-term obligations, although its quick ratio of 0.58 suggests a tighter liquidity position when inventory is excluded. The company’s low debt ratio of 0.064 and a debt-to-equity ratio of 0.085 indicate minimal reliance on debt financing, presenting a strong balance sheet. However, the interest coverage ratio of -2.18 is a factor that investors may need to consider.

With the various factors in mind, MUX’s solid liquidity position, as evidenced by cash and cash equivalents of approximately $21.99 million, alongside total assets of $638.7 million against total liabilities of about $156.2 million, indicates a robust financial foundation. This financial stability, combined with the stock’s impressive market performance over the last 3 months and the positive outlook from analysts, positions McEwen Mining Inc. as a standout opportunity to review closely as investors seek opportunities in the mining sector.

The company’s Zacks Rank #1 (Strong Buy) further validates its potential for growth, placing it in the top 5% of over 4,000 stocks based on trends in earnings estimate revisions and EPS surprises. This ranking, coupled with an Average Broker Recommendation of #1 (Strong Buy), highlights McEwen Mining’s strong brokerage community support and its fundamental solidity, making it a compelling opportunity.

For more information, visit the company’s website at www.McEwenMining.com.

NOTE TO INVESTORS: The latest news and updates relating to MUX are available in the company’s newsroom at http://ibn.fm/MUX

The 7th Annual SPAC Conference Gears Up for a Resurgent Market in 2024

  • 29 SPAC deals completed in the first quarter
  • This year’s edition of The SPAC Conference will take place at New York’s luxurious Westchester Country Club on June 11-12, 2024
  • The 7th Annual conference will welcome a variety of investors, private companies, and finance professionals who will delve into the latest trends within the SPAC industry
  • The conference features 18+ keynote presentations and 25+ speakers
  • Review the full Agenda

Special purpose acquisition companies (“SPACs”) in 2021 accounted for 63% of the US IPO market.

Following a broader market downturn in 2023, which saw a number of potential issuers postpone their IPOs, the sector seems to have normalized in 2024. Six SPAC IPOs were priced over the first quarter of 2024, with the average IPO raising $114 million, up 39% relative to the same quarter last year. Meanwhile, during that same period, 29 SPACs completed their mergers with private companies; three of these were for targets with an enterprise value of over $1 billion, with the largest of the transactions – for digital investment platform, Webull, resulting in a $7.3 billion merger.

“We believe the market has now self-corrected as SPAC IPOs have normalized, SPAC liquidations have taken excess capital out of the market and more sponsor teams are working creatively to try to get deals done,” said Don Duffy, President of financial consultancy, ICR.

With this resurgence comes opportunity. But where to begin? We have the answer.

Join prospective SPAC issuers, investors and private corporate executives to discuss the state of the SPAC market as well as its inherent opportunities at the 7th Annual SPAC Conference 2024.

Hosted by renowned industry conference organizer DealFlow Events, the SPAC Conference has earned a reputation for bringing together the most influential participants in the SPAC market, with conference attendees able to learn, network, and make new connections – all in a luxurious setting. This event is packed with actionable information, socializing and after-hours entertainment.

This year’s SPAC Conference features a number of special guest speakers as well as presentations on a range of essential topics, including Distressed Opportunities in Cross-Border SPAC Acquisitions, Elements of a Seamless and Successful SPAC Transaction, as well as an insightful review session, State of the Market – SPACs Yesterday, Today, and Tomorrow. That’s just a sampling of what attendees can expect.

Some of the highly experienced and widely-respected speakers on the agenda include Doug Ellenoff, Partner, Ellenoff Grossman & Schole; Dan Nash, Co-Founder of Cohen Capital Markets; Steve Levine, CEO at EarlyBird Capital; Ed Kovary, Head of SPAC Capital Markets at BTIG; and Mark Schwartz, SPAC Capital Markets Advisory Leader at Ernst & Young, and many more. These experts are ready to share their insights and knowledge with you.

Get deals done. Make more money. It all starts with The SPAC Conference June 11-12.

This is the premiere annual event for anyone involved in any way with SPACs. Don’t miss out. Click now for additional details about the SPAC Conference, including registration.

SOBRsafe Inc. (NASDAQ: SOBR), An Advanced Alcohol Detection Solutions Provider, Signs Two New Agreements Covering Multiple Facilities, Eyes Additional Orders

  • SOBRsafe recently secured two new contracts: a hardware/software agreement with a Southern California-based behavioral health provider operating three facilities, and a reseller agreement with a new San Antonio, Texas-based channel partner
  • The behavioral health provider purchased and installed a SOBRcheck(TM) device in each of its three facilities to facilitate point-of-care alcohol screening
  • SOBRcheck(TM) has been shown to streamline operations and reduce expenses, delivering results instantaneously compared to 45 seconds per person in cases where breathalyzer tests were administered
  • SOBRsafe’s new channel partner purchased an initial three SOBRcheck(TM) devices and two SOBRsure(TM) wearable wristbands and plans to place an additional order for both devices
  • So far in 2024, SOBRsafe has secured 18 new accounts, compared to three accounts booked in all of 2023

Committed to creating a culture of prevention and support through its suite of advanced touch-based alcohol detection solutions and a powerful backend data platform, SOBRsafe (NASDAQ: SOBR) provides next-generation technology for the behavioral health, judicial and consumer markets. In the first quarter of 2024, the company secured 16 new contracts to provide its products, which, according to the company’s Chairman and CEO, Dave Gandini, represented “just the beginning of our broad adoption in behavioral health and justice” (https://ibn.fm/d9Zc8).

As a testament to the increasing adoption of its products, SOBRsafe recently celebrated the signing of a hardware/software agreement with a Southern California-based behavioral health provider operating three facilities. The customer – who offers inpatient detoxification, residential treatment and outpatient services – purchased and installed a SOBRcheck(TM) device in each of its three facilities to facilitate point-of-care alcohol screening. SOBRcheck(TM)’s installation is expected to streamline operations at the three facilities with real-time results reporting. It is also expected to eliminate expenses through its unmanned screening capabilities (https://ibn.fm/Dma8k).

SOBRcheck(TM) was SOBRsafe’s launch product. It is a high-volume passive alcohol screening solution that is fitted with a transdermal sensor to detect alcohol excreted through the skin, providing results automatically and in seconds. In addition to alcohol detection, the device supports biometric identification; it simultaneously scans a person’s fingerprint during alcohol screening and, as a result, ties the alcohol scan results to that person’s ID in a privacy-compliant manner. This way, SOBRcheck(TM) prevents circumvention and enhances security. Beyond scanning, the device wirelessly delivers the results to a central dashboard for immediate appropriate action.

SOBRcheck(TM)’s unique capabilities have been shown to dramatically reduce the time spent screening persons and recording the results. Earlier this year, SOBRsafe released a case study that detailed how Alternatives, Inc., a Billings, Montana-based non-profit providing alternatives to incarceration for federal, state and local offenders, has benefited from integrating SOBRcheck(TM) into its operations. Alternatives installed SOBRcheck(TM) at one of its facilities, a men’s pre-release center called Alpha House that serves as an intermediate step between prisons and the community.

“When the facility was using the traditional breathalyzer, the average process time – with the breathalyzer test, checking IDs, and manually recording data – was 45 seconds per person. Conversely, SOBRcheck(TM) delivers the client’s identity verification and alcohol status in just 10 seconds,” reads the case study (https://ibn.fm/bsDFB).

In addition to the hardware/software agreement, SOBRsafe also reported the signing of a reseller agreement with a new San Antonio, Texas-based channel partner, Alcohol Monitoring Solutions (d/b/a 365IID), servicing the justice, workplace safety, and family law markets. For its part, 365IID purchased an initial three SOBRcheck(TM) devices and two SOBRsure(TM) wearable wristbands. (SOBRsure(TM), SOBRsafe’s second product, is a transdermal, alcohol-detecting wearable that provides continuous, mobile alcohol monitoring.)

The channel partner plans to place an additional order for both devices. According to the announcement, 365IID is presenting the SOBRsafe technology in the San Antonio and El Paso areas for pre-trial and Drug Court applications, as well as for workplace safety in warehouses.

With the two most recent agreements now activated, SOBRsafe has now secured 18 new accounts in 2024, compared to three accounts booked in all of 2023. The company is positioned for accelerated growth. “We believe that success breeds success and that these new relationships will spark additional and larger deals. To fuel this growth, we have a strong team of four direct sales professionals and eight behavioral health field affiliates across key markets,” said Gandini during a presentation delivered last month as part of the Lytham Partners Spotlight Series (https://ibn.fm/2CTDH).

In addition to targeting the behavioral health, judicial and consumer markets, the company is also eyeing licensing and integration. “We also continue to talk with industry players about potentially using our patent-pending SOBRsafe technology and unique data in their third-party devices and software. While nothing is imminent, a licensing or integration deal would be a means of generating non-dilutive capital and could be a source of ongoing royalty revenue,” hinted Gandini.

For more information, visit the company’s website at www.SOBRsafe.com.

NOTE TO INVESTORS: The latest news and updates relating to SOBR are available in the company’s newsroom at https://ibn.fm/SOBR

Innovative Water-generation Contract Amid Significant Mexico Drought Demonstrates Significant Market Opportunity for Energy and Water Development Corp. (EAWD)

  • Significant drought conditions in Mexico with months to go before the fall rainy season have led to concerns one of the world’s most populous cities may soon run entirely out of water, with residents currently struggling to make the most of a limited supply
  • Innovative green tech engineering services company Energy and Water Development Corp. has entered an MOU with some of the city’s residents to create first-of-its-kind Off-Grid Atmosphere Water Generation Plant that will extract moisture from the air to ease the crisis
  • The facility is expected to generate about 3.2 million liters of water annually, with a later phase planned to produce millions more liters of water than the original plant
  • EAWD is headquartered in Florida and has operations in Germany, where it is also developing solar-powered Off-Grid electric vehicle (“EV”) Charging Stations

A group of indigenous and non-indigenous people, gathering at an archaeological site in Mexico City earlier to pray for rain, highlighted concerns about a drought gripping much of the country (https://ibn.fm/fH3Ix).

Around 60 percent of Mexico is experiencing moderate to exceptional drought, according to the National Commission on Water (https://ibn.fm/No9gG). Mexico City is facing a severe water crisis, with experts fretting the metropolis of nearly 22 million people may run entirely out of water before the rainy season begins in the fall (https://ibn.fm/S79EA).

Amid the crisis, “several significant landowners of the Magdalena Contreras Municipality” of Mexico City, where more than 200,000 of the city’s residents live, signed a joint Memorandum of Understanding (“MOU”) with Florida-based green tech engineering services company Energy and Water Development (OTCQB: EAWD) in December to deploy the company’s first Off-Grid Atmosphere Water Generation Plant on the American continent.

“The Off-Grid Atmosphere Water Generation Plant is set to revolutionize how we address water scarcity challenges,” Energy and Water Development Corp. CEO Irma Velazquez stated in the company’s announcement of the project (https://ibn.fm/wp4SA). “In its initial phase, the plant is expected to produce approximately 3.2 millions of liters of water annually by extracting moisture directly from the air. This project represents a beacon of hope in the face of severe water scarcity and offers a sustainable, off-grid solution to ensure a reliable and sustainable source of clean water for Mexico City residents.”

The first phase of the plant will span 5,000 square meters, with subsequent phases adding a 30-hectare facility capable of producing millions more liters of water than the original plant. EAWD has also sold a similar system in Germany, and the company is working to develop additional orders.

EAWD is focused on delivering water and energy to extreme environments, emphasizing self-sufficient energy-supplied water generation and green energy production. Its patent-pending off-grid, self-sufficient energy supply atmosphere water generation (“AWG”) systems and solar-powered EAWD Off-Grid EV Charging Stations are built in Hamburg, Germany through subsidiaries EAWD Deutschland and EAWD Logistik.

Energy and Water Development Corp.’s most recent annual financial statement cited a United Nations Educational, Scientific and Cultural Organization (“UNESCO”) report noting that worldwide 2 billion people (26 percent of the planet’s population) do not have safe drinking water and 3.6 billion lack access to safely managed sanitation.

“This organization has identified an urgent need to establish strong international mechanisms to prevent the global water crisis from spiraling out of control,” the filing states (https://ibn.fm/YQTKI). “Recognizing the pressing nature of these challenges, EAWD is committed to crafting sustainable and renewable solutions. As such, EAWD is poised to become a pivotal player in an industry that is not only rapidly expanding, but also unlocking numerous new markets in response to these urgent environmental issues.”

In associated news, the company announced the April appointment of Bevilacqua PLLC as its new counsel for matters related to the U.S. Securities and Exchange Commission (“SEC”) and capital markets to strengthen its compliance and legal operations under market guidelines. EAWD regards the move as evidence of its commitment to uphold rigorous regulatory standards and promote corporate transparency (https://ibn.fm/YtdsJ).

For more information, visit the company’s website at www.Energy-Water.com.

NOTE TO INVESTORS: The latest news and updates relating to EAWD are available in the company’s newsroom at http://ibn.fm/EAWD

Lexaria Bioscience Corp. (NASDAQ: LEXX) Partners with the National Research Council of Canada for DehydraTECH-GLP-1 Mode of Action Investigation

  • Lexaria, a global innovator in drug delivery platforms, just announced its newest relationship with the National Research Council of Canada (“NRC”)
  • Specific molecular characteristics of the glucagon-peptide 1 (“GLP-1”) drug, semaglutide, processed with Lexaria’s patented DehydraTECH(TM) technology, will be evaluated
  • Previous research has shown that using a DehydraTECH-semaglutide capsule composition yields a 43% higher peak level of semaglutide in blood compared to Rybelsus(R). This has potential for increased weight-loss and diabetic control
  • Lexaria’s management is confident that this partnership will complement the company’s animal and human pharmacokinetic and pharmacodynamic studies for the 2024 calendar year

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has announced a partnership with the National Research Council of Canada (“NRC”) that will pursue an applied research program to evaluate specific molecular characteristics of the company’s patented DehydraTECH(TM) technology processed with glucagon-peptide 1 (“GLP-1”) drug, semaglutide, related to its mode of action and performance (https://ibn.fm/7ThTn).

The work program will utilize simulated gastric fluid, mimicking conditions in the human gut. In addition, various testing methods will be employed, among them size exclusion chromatography (“SEC”), polyacrylamide gel electrophoresis (“PAGE”), dynamic light scattering (“DLS”), and matrix-assisted laser desorption ionization mass spectrometry (“MALDI MS”).

GLP-1 drugs have shown significant benefits in weight management and addressing diabetes. Previous research has shown that using a DehydraTECH-semaglutide capsule composition yields a 43% higher peak level of semaglutide in blood than an unprocessed Rybelsus(R) tablet. The benefits also extend to doing away with painful injections, which are the norm with GLP-1 delivery.

Lexaria’s management believes this partnership could help fast-track the company’s push for the adoption of DehydraTECH with GLP-1 drugs. It will also be integral in showcasing the potential of the technology while inching the company closer to tapping into an industry projected to be valued at $133.5 billion by 2030 (https://ibn.fm/urgRt).

“We are excited about our partnership with the NRC for the mode of action molecular characterization of DehydraTECH-GLP-1 drugs. This work program could potentially provide data to assist Lexaria’s efforts in partnering with the pharmaceutical industry for the most rapid introduction possible of DehydraTECH with GLP-1 drugs,” noted John Docherty, Lexaria’s president.

This partnership follows Lexaria’s resolve to double down on GLP-1 studies for the 2024 calendar year. It also follows the recent independent third-party ethics review board approval for its GLP-1 human pilot study #2, which seeks to explore the oral delivery of GLP-1 drugs. In addition, in March Lexaria announced details of its WEIGHT-A24-1 animal study which will examine diabetes and weight loss effects of DehydraTECH-processed GLP-1 drugs and DehydraTECH-processed cannabidiol, alone and in combination (https://ibn.fm/kSOLl).

Lexaria’s management is confident that by identifying the molecular behavior of DehydraTECH-processed pure semaglutide compositions, the findings will complement the company’s animal and human pharmacokinetic and pharmacodynamic studies for the 2024 calendar year. In addition, it is hopeful that this could ultimately lead to alternative formulations with enhanced performance. The program is expected to be completed in early August, with results reported as soon as possible after that.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

HealthLynked Corp. (HLYK) Setting New Standard for Efficient Healthcare, Including Virtual Healthcare

  • HealthLynked leverages innovative cutting-edge technology and connectivity to make healthcare more efficient for patients and doctors
  • The company’s HealthLynked Network, a comprehensive and sophisticated cloud-based healthcare platform, connects patients, healthcare providers, and medical facilities, providing centralized information access and communication
  • Through its sophisticated platform, HealthLynked is changing how patients and medical professionals can, for example, interact with telehealth and telemedicine services
  • The network facilitates real-time interactions between healthcare providers and patients, greatly improving the efficient delivery of healthcare information and services remotely through a user-facing app, securely transmitting needed patient data on demand

HealthLynked (OTCQB: HLYK) offers cutting-edge technology and connectivity to provide more efficient, accessible, and personalized healthcare, through centralized and integrated information management and access. Among other things, HealthLynked greatly improves the use and effectiveness of remote patient care, such as telemedicine, telehealth, remote monitoring, and direct-to-consumer lab testing.

At the heart of the system is the HealthLynked Network, the company’s comprehensive and sophisticated cloud-based healthcare platform that securely, efficiently, and cost-effectively connects patients, healthcare providers, and medical facilities. The platform’s offerings include centralizing and securing medical records and data (including personal health records, past surgeries, allergies, and medications), appointment scheduling, telemedicine, patient engagement tools, and more.

“With HealthLynked [Network], patients can easily store and share their medical information with healthcare providers, receive reminders for appointments and preventative care, and access educational resources. Healthcare providers can use the platform to manage patient records, communicate with other providers, and offer telemedicine services. In addition, medical facilities can benefit from the platform’s centralized scheduling and administrative tools, as well as the ability to offer patients a comprehensive suite of services through a single platform,” explains the company’s investor presentation (https://ibn.fm/zpN7z).

Through this sophisticated platform, HealthLynked is changing how patients and medical professionals interact and communicate, including greatly improved telehealth and telemedicine effectiveness. Telehealth, a broad term that captures all forms of healthcare services delivered remotely via technology and connected systems, differs from telemedicine, which refers to a subset of healthcare that only focuses on offering clinical services via technology. Whereas telehealth broadly covers services like health education, mental health services, and other non-clinical interactions, telemedicine only encompasses services offered in a clinical setting via technology, including testing, diagnosing, and medical conditions. HealthLynked Network is a transformative force in telehealth, pushing the boundaries of traditional services and eliminating the barriers that once restricted access to medical services.

Here’s a closer look at how HealthLynked is redefining patient care:

  1. Telehealth Accessibility Beyond Employer-Sponsored Programs: Traditionally, telehealth services have been accessible primarily through employer-sponsored programs, limiting availability to a subset of patients. HealthLynked’s approach broadens this accessibility by offering a comprehensive online network, ensuring that individuals beyond these programs can seamlessly connect with healthcare providers.
  2. From Telehealth to Telemedicine: While telehealth encompasses various healthcare services, telemedicine specifically involves providing clinical care using a patient’s medical history and current health data. HealthLynked’s platform is uniquely positioned to bridge this gap, offering a robust network that enables healthcare professionals to make well-informed decisions with comprehensive patient information at their fingertips.
  3. Expanding Mental Health Services: Mental health services are a vital aspect of telehealth due to their straightforward nature. HealthLynked’s advanced network allows for specialized telemedicine services within mental health care, providing comprehensive support tailored to each patient’s unique needs.
  4. Bridging the Gap in Women’s Health: Despite the rise in telehealth, there remains a significant gap in services for women’s health, such as contraceptive management and hormonal therapy. HealthLynked aims to close this gap by expanding telemedicine capabilities to include these vital services, empowering women with accessible and convenient care tailored to their unique needs.
  5. At-Home Testing and Routine Screening: HealthLynked recognizes the need for convenient and reliable health screening at home. By providing tools and resources for at-home testing, they enable patients to monitor their health through routine screenings without visiting a clinic. This approach enhances early detection and preventative care, which are essential components of effective healthcare.
  6. Remote Monitoring: HealthLynked employs technology to monitor patients’ health data remotely, such as vital signs, blood sugar levels, or heart rate, without requiring the patient to visit a healthcare facility. This proactive approach allows healthcare professionals to provide continuous and comprehensive care.
  7. Mobile Health (mHealth): HealthLynked incorporates mobile devices like smartphones and tablets to deliver healthcare services and information remotely. Apps for symptom tracking, medication reminders, and virtual consultations are seamlessly integrated, offering patients a convenient way to manage their health from the palm of their hand.
  8. Store-and-Forward: HealthLynked’s platform transmits patient data, such as medical images or test results, to specialists or other healthcare professionals for evaluation at a later time. This eliminates the need for immediate consultations, providing flexibility for patients and healthcare providers while ensuring that patient information is available for comprehensive evaluations.
  9. Remote Consultations: Real-time interactions between healthcare providers and patients are enabled via video calls, phone calls, or secure messaging to diagnose, treat, or provide medical advice remotely. HealthLynked’s secure network ensures that these consultations remain private and effective, bridging geographical distances and reducing barriers to healthcare access.
  10. Expanding Telehealth Capabilities: Expanding telehealth to include specialized telemedicine services requires a network that can handle the complexities of remote patient monitoring and seamless information sharing. HealthLynked excels in this area, using its cutting-edge network capabilities to provide a more holistic and integrated healthcare experience, empowering both patients and providers.

In conclusion, HealthLynked is a transformative force in telehealth, pushing the boundaries of traditional services to deliver comprehensive care. By expanding access and leveraging advanced network capabilities, they are setting a new standard for virtual healthcare, particularly in women’s health and at-home testing.

For more information, visit the company’s website at www.HealthLynked.com.

NOTE TO INVESTORS: The latest news and updates relating to HLYK are available in the company’s newsroom at https://ibn.fm/HLYK

Illinois Cannabis Convention & Expo to Attract the Biggest Traders in the Cannabis Spectrum

The NECANN Illinois Cannabis Convention 7 Expo is being held May 31 – June 1, 2024, at the Schaumburg Convention Center, Chicago, IL. One of the biggest cannabis B2B conventions in the country, the event will witness prominent growers, traders, enthusiasts, patients, educators, dealers, and top industry leaders.

Newcomers as well as seasoned businesses can showcase their products or unique ideas at the exhibitor booths to gain visibility among the top investors, industries, and traders in the cannabis industry. The exhibitor booths significantly attract the crowds as they have fresh and innovative items on display.

Operating since 2014, NECANN events are constantly expanding, offering knowledge, and a robust platform for networking & collaborations, all under one roof. The NECANN events attract a huge number of local businesses and communities of the cannabis industry, providing them with singular growth and business opportunities.

The attendees can create their own personalized schedules, bookmarking those events that they want to attend. Several eminent leaders will be conducting speaker sessions where they will share their invaluable insights and knowledge to design winning marketing strategies in a highly competitive landscape. The discussion panels will discuss new trends and strategies for the cannabis market to help businesses drive higher ROI. Participants can gain know-how about the latest trends in the cannabis industry by attending the many exhibitor booths at the event.

Topics of discussion range from business & growth, cultivation, social equity, tracks, and trends. Investors seeking new avenues for trade need to explore the event as NECANN attracts a large number of vendors from across the country. From enthusiasts to business founders, the NECANN Illinois Convention & Expo has the richest selection of opportunities to offer in the cannabis community.

To know more, please visit https://ibn.fm/d7p0a.

Waste Innovations: Catalyzing Sustainability in Orange County

Sustain SoCal, in association with Orange County Waste and Recycling, is organizing a Waste Stream Management and Circularity Event on May 15, 2024, at the Frank R. Bowerman Landfill, Irvine, CA. Sustain SoCal focuses on exploring, analyzing, and implementing workable solutions for the many energy and sustainability issues in Southern California.

The board at SoCal consists of experienced dignitaries who focus on key sectors of water, energy, and transportation. Under sound leadership, the team at Sustain SoCal conducts conferences, workshops, and networking events. Sustain SoCal accelerates economic growth by addressing the challenges and finding sustainable solutions through innovation, collaboration, and education.

The agenda of the SoCal conference is to find current and potential solution sets for waste sorting, landfill management, organics infrastructure, public education, composting, SB54 on extended producer responsibility, PFAS/PFOA, and more.

The event is sponsored by OC Waste & Recycling, an organization catering to the solid waste disposal services of the County. They protect the local environment by investing in renewable energy enterprises, offering waste management services, operating public landfills, and promoting recycling to ensure a safe and healthy community for current and future generations.

The SoCal Waste Stream Management And Circularity conference is co-sponsored by BioLargo, Inc. which has thirteen years of experience in developing and commercializing innovative platform technologies to solve challenging environmental issues.

The event will be attended by an impressive line-up of eminent speakers. They will identify and discuss the challenges and offer their insights on better waste management in the county. Attendees can gather knowledge, information, business ideas, and work on solutions to achieve economic progress and a sustainable future for the area, its residents, and businesses.

To learn more, please visit https://ibn.fm/LlzO7

Rising Tide of EM Consideration by Courts Helps Boost Market for SuperCom Ltd. (NASDAQ: SPCB) Suite of Electronic Monitoring Technology and Services

  • SuperCom Ltd. has successfully introduced its suite of PureSecurity electronic monitoring products and services in several countries, including the United States
  • America’s vast federal and lower court system is a particular factor for SuperCom because of the courts’ drive to consider alternatives to incarceration, providing non-violent offenders options for remaining out of overcrowded jails prior to trial or after sentencing
  • SuperCom has successfully won and serviced a variety of new multi-year government client projects, showing the ongoing need for continually improving EM technology

Court systems everywhere, including the U.S., rely on probation and parole programs to help reduce the expense and staffing pressures associated with maintaining non-violent offenders behind bars (https://ibn.fm/tZB71).

An earlier report on the use of electronic monitoring (“EM”) in Los Angeles County, where EM is used as a cost-efficient way of keeping people out of jail, found that between 2015 and 2021, the number of people subject to EM before trial rocketed from 24 to 1,284 and that one major courthouse was choosing EM over standard alternative monitoring options in 92 percent of supervised release referrals (https://ibn.fm/pYX4K).

Citing a study by the nonprofit Vera Institute of Justice, the report also noted that between 2021 and 2022 there were an estimated half a million people in the criminal justice and civil immigration systems on some form of electronic monitoring in the United States, and that there was a five-fold increase in EM use nationwide (https://ibn.fm/Dz0yG).

SuperCom (NASDAQ: SPCB) is an EM technology company that has worked with clients in both Europe and the U.S., with a key focus on the United States court-administered supervised release programs that aim to reduce recidivism as well as demands on the U.S. incarceration system. EM is designed as a downward pressure on both.

SuperCom’s end-to-end suite of EM solutions includes state-of-the-art GPS tracking in real-time, secured communication, and other technologies. Their monitors can be worn discreetly, minimizing the likelihood that someone being supervised electronically may be stigmatized by peers or employers, encouraging a controlled return to the outside world.

The company’s recent detailed financial report showed revenues have more than doubled since 2021, with gross profits increasing and gross margin growing to 41.4 percent. In 2023, the company returned to “normal operations” in a context that significantly contrasts with the Covid-impacted years of 2021 and 2022.

For more information, visit the company’s website at www.SuperCom.com.

NOTE TO INVESTORS: The latest news and updates relating to SPCB are available in the company’s newsroom at http://ibn.fm/SPCB

Torr Metals Inc. (TSX.V: TMET) Hits the Bullseye: Uncovers Multiple Untested Copper and Gold Porphyry Targets at the Highway-Accessible Kolos Project 

Torr Metals (TSX.V: TMET) is excited about what it is seeing in new preliminary results from its Kolos Copper-Gold Project in British Columbia. Utilizing sophisticated geophysical techniques, the company has identified extensive anomalies stretching from mineralized outcrop at-surface to over 1.5 kilometers in depth, where there is strong potential for sub-surface extensions to copper and gold mineralization.

Advanced computer modeling (3D resistivity inversion voxel model) of a recently completed ZTEM geophysical survey pinpointed these fruitful drill targets across Torr’s 100% owned, 140-square-kilometer Kolos Copper-Gold Project. Excitement is particularly heightened against the backdrop of a strategic land position, as the Kolos project is located just 30 kilometers from Teck Resources’ Highland Valley, a copper and molybdenum operation and Canada’s largest open pit copper mine.

4 Key Findings at Kolos

  1. Large-Scale Anomalies. The 3D resistivity inversions revealed multiple untested areas with potential for substantial porphyry deposits, particularly within the Lodi, Kirby, and Clapperton Zones where the geophysical anomalies are most robust. Two additional high-priority targets were identified in the Ace and Rea Zones, exhibiting characteristics of copper-gold porphyry-epithermal systems.
  2. Strong Correlation with Surface Mineralization. The resistivity anomalies align closely with known zones of copper-gold and copper-molybdenum mineralization found at the surface in outcrop, a key characteristic that provides considerable de-risking in future drill targeting. This strengthens the case for the extension of mineralization deeper underground, providing the scalability for potential multiple new major porphyry discoveries.
  3. Impressive Scale. The anomalous areas identified cover vast distances, exceeding 4.8 kilometers in strike length, while also connecting the Cu-Au Lodi and Kirby Zones at-depth. This is indicative of a cluster porphyry system suggestive of a highly fertile concentration of copper and gold mineralization at Kolos.
  4. Expansion Potential. The promising geophysical signature at the Kirby and Clapperton Zones extends beyond the limits of the current soil sampling grid, indicating a possibility for further discoveries with additional exploration efforts.

Moving Forward

These findings provide Torr Metals with a clear roadmap for future exploration activities. Armed with precise data on the location and characteristics of the anomalies and a pending drill permit, the company can now plan targeted drilling campaigns with greater efficiency. “We are now identifying the robust plumbing behind these prolific mineralizing systems, indicating an immense scale of underlying potential,” said Malcolm Dorsey, Torr Metals President and CEO.

And this is just the beginning. With several untested zones spread across a 7-kilometer porphyry trend, the Kolos Project presents an enticing opportunity with the potential to uncover multiple new major copper-gold discoveries within Canada’s most prolific copper mining belt.

Strategic Location

Located close to Highland Valley is reason to increase bullishness about the potential for Kolos, but it has other benefits too. The project’s pre-existing road access to all high-priority targets and proximity to Highway 5 with all the requisite regional mining infrastructure adds further appeal. With year-round operation potential a successful discovery at Kolos could translate into a new mine, creating jobs and boosting the regional economy.

A Word on ZTEM

ZTEM geophysics has played a crucial role in these advancements. Think of it as acting like a powerful MRI machine, revealing metal-rich areas deep in the Earth. This advanced surveying method excels at identifying large-scale hydrothermal systems associated with porphyry deposits, as Kolos is.

Its ability to map intricate geological structures is invaluable for pinpointing potential mineralized zones, ultimately leading to a more targeted and successful exploration strategy. Up next for Torr Metals will be further surface exploration to expand on existing targets as well as drilling, pending permit approval, a development that frequently leads to rising valuations.

For more information, visit the company’s website at www.TorrMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to TMET are available in the company’s newsroom at https://ibn.fm/TMET

From Our Blog

Lixte Biotech Holdings Inc. (NASDAQ: LIXT) Advances Precision Oncology Strategy with LB-100, Expands Clinical and Strategic Partnerships

April 9, 2026

Lixte Biotechnology (NASDAQ: LIXT) is emerging as a differentiated player in the oncology ecosystem, advancing a precision-driven approach to cancer treatment which focuses on improving the effectiveness of existing. As a clinical-stage pharmaceutical company, the company is advancing novel compounds built around a unique biological target, with its lead candidate, LB-100, at the nucleus of […]

Rotate your device 90° to view site.